1McConnell J D, Roehrborn C G, Bautista O M, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia [J ]. N Engl J Med, 2003, 349: 2387-2398.
2Jimenez-Cruz F. Identifying patients with lower urinary tract symptoms/ benign prostatic hyperplasia at risk for progression[J]. Eur Urol, 2003, 2: 6--12.
3Jacobsen S J, Jacobson D J, Girman C J, et al. Natural history of prostatism: risk factors for acute urinary retention[J]. J Urol, 1997, 158:481-487.
4Roehrborn C G, Malice M, Cook T J, et al. Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH : a comprehensive analysis of the pooled placebo groups of several large clinical trials[J]. Urology, 2001, 58:210-216.
5Emberton M, Cornel E B, Bassi P F, et al. Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management [J]. Int J Clin Praet, 2008, 62: 1076-1086.
6Price D. Potential mechanisms of action of superselective alpha ( 1)-adrenoceptor antagonists [J]. Eur Urol, 2001,40 (suppl 4) : 5-11.
7Jacobsen S J, Jacobson D J, Girman C J, et al. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status[J]. J Urol, 1999, 162: 1301-1306.
8MeConnell J D, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary reten tion and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long Term Efficacy and Safety Study Group[J]. N Engl J Med, 1998, 338:557--563.
9Crawford E D, Pinsky P F, Chia D, et al. Prostate specific antigen changes as related to the initial prostate specific antigen., data from the prostate, lung, colorec tal and ovarian cancer screening trial[J]. J Urol ,2006, 175: 1422-1426.
10Levin R M, Levin S S, Zhao Y, et al. Cellular and molecular aspects of bladder hypertrophy[J]. Eur Urol , 1997, 32(suppl 1) :15-21.
2Djavan B, Shariat S, Fakhari M, et al. Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial. Urology, 1999, 53: 251-259.
3Djavan B, Ghawidel K, Basharkhah A, et al. Temporary intraurethral prostatic bridge-catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy. Urology, 1999, 54 : 73- 81.
